Federal Register / Vol. 80, No. 16 / Monday, January 26, 2015 / Notices 3987 

Controlled 

Substance Schedule 

2-(2,5-Dimethoxy-4-nitro-phenyl) 

ethanamine (2C–N) (7521).

I 

2-(2,5-Dimethoxy-4-(n)- 

propylphenyl) ethanamine (2C– 

P) (7524).

I 

2-(4-Isopropylthio)-2,5- 

dimethoxyphenyl) ethanamine 

(2C–T–4) (7532).

I 

MDPV (3,4- 

Methylenedioxypyrovalerone) 

(7535).

I 

2-(4-bromo-2,5-dimethoxyphenyl)- 

N-(2-methoxybenzyl) 

ethanamine (25B–NBOMe) 

(7536).

I 

2-(4-chloro-2,5-dimethoxyphenyl)- 

N-(2-methoxybenzyl) 

ethanamine (25C–NBOMe) 

(7537).

I 

2-(4-iodo-2,5-dimethoxyphenyl)-N- 

(2-methoxybenzyl) ethanamine 

(25I–NBOMe) (7538).

I 

Methylone (3,4-Methylenedioxy-Nmethylcathinone) (7540).I 

Butylone (7541) ............................ I 

Pentylone (7542) .......................... I 

alpha-pyrrolidinopentiophenone 

(a-PVP) (7545).

I 

alpha-pyrrolidinobutiophenone (a 

-PBP) (7546).

I 

AM–694 (1-(5-Fluoropentyl)-3-(2- 

iodobenzoyl) indole) (7694).

I 

Acetyldihydrocodeine (9051) ........ I 

Benzylmorphine (9052) ................ I 

Codeine-N-oxide (9053) ............... I 

Desomorphine (9055) ................... I 

Codeine methylbromide (9070) .... I 

Dihydromorphine (9145) ............... I 

Heroin (9200) ............................... I 

Hydromorphinol (9301) ................. I 

Methyldesorphine (9302) .............. I 

Methyldihydromorphine (9304) ..... I 

Morphine methylbromide (9305) .. I 

Morphine methylsulfonate (9306) I 

Morphine-N-oxide (9307) ............. I 

Normorphine (9313) ..................... I 

Pholcodine (9314) ........................ I 

Acetylmethadol (9601) ................. I 

Allylprodine (9602) ....................... I 

Alphacetylmethadol except levoalphacetylmethadol (9603).I 

Alphameprodine (9604) ................ I 

Alphamethadol (9605) .................. I 

Betacetylmethadol (9607) ............ I 

Betameprodine (9608) .................. I 

Betamethadol (9609) .................... I 

Betaprodine (9611) ....................... I 

Dipipanone (9622) ........................ I 

Hydroxypethidine (9627) .............. I 

Noracymethadol (9633) ................ I 

Norlevorphanol (9634) .................. I 

Normethadone (9635) .................. I 

Trimeperidine (9646) .................... I 

Phenomorphan (9647) ................. I 

1-Methyl-4-phenyl-4- 

propionoxypiperidine (9661).

I 

Tilidine (9750) ............................... I 

Para-Fluorofentanyl (9812) .......... I 

3-Methylfentanyl (9813) ................ I 

Alpha-methylfentanyl (9814) ........ I 

Acetyl-alpha-methylfentanyl 

(9815).

I 

Beta-hydroxyfentanyl (9830) ........ I 

Controlled 

Substance Schedule 

Beta-hydroxy-3-methylfentanyl 

(9831).

I 

Alpha-methylthiofentanyl (9832) ... I 

3-Methylthiofentanyl (9833) .......... I 

Thiofentanyl (9835) ...................... I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Lisdexamfetamine (1205) ............. II 

Phenmetrazine (1631) .................. II 

Methylphenidate (1724) ................ II 

Amobarbital (2125) ....................... II 

Pentobarbital (2270) ..................... II 

Secobarbital (2315) ...................... II 

Glutethimide (2550) ...................... II 

Nabilone (7379) ............................ II 

1-Phenylcyclohexylamine (7460) II 

Phencyclidine (7471) .................... II 

1- 

Piperidinocyclohexanecarbonitrile (8603).

II 

Alphaprodine (9010) ..................... II 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Diphenoxylate (9170) ................... II 

Ecgonine (9180) ........................... II 

Ethylmorphine (9190) ................... II 

Hydrocodone (9193) ..................... II 

Levomethorphan (9210) ............... II 

Levorphanol (9220) ...................... II 

Isomethadone (9226) ................... II 

Meperidine (9230) ........................ II 

Meperidine intermediate-A (9232) II 

Meperidine intermediate-B (9233) II 

Meperidine intermediate-C (9234) II 

Metazocine (9240) ........................ II 

Methadone (9250) ........................ II 

Methadone intermediate (9254) ... II 

Dextropropoxyphene, bulk (nondosage forms) (9273).II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Levo-alphacetylmethadol (9648) .. II 

Oxymorphone (9652) ................... II 

Noroxymorphone (9668) .............. II 

Racemethorphan (9732) .............. II 

Alfentanil (9737) ........................... II 

Remifentanil (9739) ...................... II 

Sufentanil (9740) .......................... II 

Carfentanil (9743) ......................... II 

Tapentadol (9780) ........................ II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

small quantities of the listed controlled 

substances to make reference standards 

which will be distributed to their 

customers. 

Dated: January 9, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01300 Filed 1–23–15; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Manufacturer of Controlled 

Substances Registration: Apertus 

Pharmaceuticals 

ACTION: Notice of registration. 

SUMMARY: Apertus Pharmaceuticals 

applied to be registered as a 

manufacturer of a certain basic class of 

controlled substance. The DEA grants 

Apertus Pharmaceuticals registration as 

a manufacturer of the controlled 

substance. 

SUPPLEMENTARY INFORMATION: By notice 

dated May 28, 2014, and published in 

the Federal Register on June 4, 2014, 79 

FR 32321, Apertus Pharmaceuticals, 331 

Consort Drive, St. Louis, Missouri 

63011, applied to be registered as a 

manufacturer of a certain basic class of 

controlled substance. No comments or 

objections were submitted to this notice. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Apertus Pharmaceuticals to 

manufacture the basic class of 

controlled substance is consistent with 

the public interest and with United 

States obligations under international 

treaties, conventions, or protocols in 

effect on May 1, 1971. The DEA 

investigated the company’s maintenance 

of effective controls against diversion by 

inspecting and testing the company’s 

physical security systems, verifying the 

company’s compliance with state and 

local laws, and reviewing the company’s 

background and history. 

Therefore, pursuant to 21 U.S.C. 

823(a), and in accordance with 21 CFR 

1301.33, the above-named company is 

granted registration as a bulk 

manufacturer of Remifentanil (9739), a 

basic class of controlled substance listed 

in schedule II. 

The company plans to manufacture 

small quantities of the listed controlled 

substance to make reference standards 

for distribution to their customers. 

On March 27, 2014, Apertus 

Pharmaceuticals withdrew its request 

for the addition of Alfentanil (9737), 

Sufentanil (9740), and Fentanyl (9801) 

to this registration. 

Dated: January 9, 2015. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator. 

[FR Doc. 2015–01306 Filed 1–23–15; 8:45 am] 

BILLING CODE P 


emcdonald on DSK67QTVN1PROD with NOTICES